News

Motive Launches Comprehensive Roadside Assistance for Fleets

Motive Launches Comprehensive Roadside Assistance for Fleets

Enhancing Fleet Safety with Motive Roadside Assistance

Motive, a leader in AI-powered Integrated Operations Platforms, has recently unveiled its new service, Motive Roadside Assistance. Designed to provide comprehensive 24/7 support, this service aims to significantly enhance driver safety and operational efficiency for commercial fleets, particularly during the challenging winter months.

Addressing the Challenges of Winter Driving

The winter season brings unique challenges for drivers. With slippery roads and unpredictable weather conditions, the need for reliable roadside assistance becomes increasingly critical. Motive’s Roadside Assistance connects drivers to a vast network of over 75,000 service providers across North America, ensuring they can receive timely help, even in remote areas. This partnership with Roadzen’s National Automobile Club (NAC) is especially beneficial for commercial drivers, who often face unexpected breakdowns.

Statistics Highlighting Winter Risks

Data points indicate that the holiday season poses significant risks on the roads. Notably, the period around Christmas sees a staggering 32% increase in accident rates. A recent report indicated that winter weather plays a role in approximately 65.5% of collisions. With these statistics in mind, Motive aims to assist drivers during these hazardous conditions, striving to reduce the number of accidents and resulting damages.

Features of Motive Roadside Assistance

Motive Roadside Assistance is packed with features designed to ensure drivers receive quick and dependable service, which is crucial for maintaining productivity. Some of the key offerings include:

Rapid Response Times

Knowing that every minute counts, Motive ensures swift service with an average call answer time of fewer than 20 seconds and service arrival within 60 minutes.

Broad Service Options

From heavy-duty towing to tire changes and fuel delivery, Motive’s service covers a wide range of issues that commercial vehicles might encounter on the road. Drivers can easily request assistance through the Motive Driver App, which simplifies the process and reduces panic during roadside emergencies.

Cost-Efficient Solutions

Motive customers benefit from significant savings on roadside assistance costs, with savings of 15-20% available. Additionally, users of the Motive Card enjoy extra discounts, ensuring that they only pay for the services they require without any hidden fees.

Improved Driver Morale

Reliable support enhances peace of mind for drivers, reducing stress and fostering a more positive workplace atmosphere. Knowing help is readily available if needed can boost overall morale on the road.

Commitment to Safety and Technology

At Motive, safeguarding drivers is the utmost priority. The platform incorporates advanced AI technology capable of detecting unsafe driving behaviors and orchestrating rapid responses to emergencies. Chief Product Officer, Jai Ranganathan emphasizes the importance of having comprehensive support in place, stating, "While our north star is to prevent collisions, we must also ensure that drivers have quick access to help when needed."

Getting Started with Roadside Assistance

Commercial fleets can easily enroll in Motive Roadside Assistance starting from the designated launch date. By selecting the “Roadside Assistance” option within the Driver App, fleet owners can access this vital service without any ongoing fees, offering peace of mind during the most unpredictable months of the year.

About Motive

Motive continues to empower operations across various industries with its robust platform that unites safety, operations, and financial management. Serving over 120,000 customers, including major corporations across sectors such as transportation, construction, and energy, Motive remains committed to improving safety and efficiency within physical operations.

About National Automobile Club

A wholly owned subsidiary of Roadzen Inc. (Nasdaq:RDZN), the National Automobile Club has long been recognized for its reliable claims management and roadside assistance services. With a focus on safety and performance, NAC supports a diverse range of commercial fleets, ensuring they are well-equipped to handle the demands of their operations.

Frequently Asked Questions

What is Motive Roadside Assistance?

Motive Roadside Assistance is a 24/7 support service that provides commercial drivers with quick access to roadside help through a vast network of service providers.

How does the service improve driver safety?

The service enhances driver safety by ensuring rapid response times, minimizing downtime during emergencies, and offering peace of mind while on the road.

Are there discounts available for Motive Roadside Assistance?

Yes, Motive customers can enjoy discounts of up to 20% on roadside assistance costs, along with additional savings for those using the Motive Card.

How can drivers request assistance?

Drivers can easily request assistance directly through the Motive Driver App, which streamlines the process and reduces response times.

What kind of services are included?

Services include heavy-duty towing, tire changes, fuel delivery, lock-out assistance, and more, addressing the diverse needs of commercial vehicles on the road.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading